These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 20220849)

  • 1. B-cell-derived lymphotoxin promotes castration-resistant prostate cancer.
    Ammirante M; Luo JL; Grivennikov S; Nedospasov S; Karin M
    Nature; 2010 Mar; 464(7286):302-5. PubMed ID: 20220849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
    Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of NF-κB-related proteins and their modulation during TNF-α-provoked apoptosis in prostate cancer cells.
    Rodríguez-Berriguete G; Fraile B; Paniagua R; Aller P; Royuela M
    Prostate; 2012 Jan; 72(1):40-50. PubMed ID: 21520161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin.
    Luo JL; Tan W; Ricono JM; Korchynskyi O; Zhang M; Gonias SL; Cheresh DA; Karin M
    Nature; 2007 Apr; 446(7136):690-4. PubMed ID: 17377533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer.
    Locke JA; Guns ES; Lubik AA; Adomat HH; Hendy SC; Wood CA; Ettinger SL; Gleave ME; Nelson CC
    Cancer Res; 2008 Aug; 68(15):6407-15. PubMed ID: 18676866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent insights into NF-κB signalling pathways and the link between inflammation and prostate cancer.
    Nguyen DP; Li J; Yadav SS; Tewari AK
    BJU Int; 2014 Aug; 114(2):168-76. PubMed ID: 24215139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
    Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G
    Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer.
    Shiota M; Yokomizo A; Naito S
    Free Radic Biol Med; 2011 Oct; 51(7):1320-8. PubMed ID: 21820046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.
    Jin RJ; Wang Y; Masumori N; Ishii K; Tsukamoto T; Shappell SB; Hayward SW; Kasper S; Matusik RJ
    Cancer Res; 2004 Aug; 64(15):5489-95. PubMed ID: 15289359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
    Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen-insensitive prostate cancer cells transiently respond to castration treatment when growing in an androgen-dependent prostate environment.
    Halin S; Hammarsten P; Wikström P; Bergh A
    Prostate; 2007 Mar; 67(4):370-7. PubMed ID: 17192959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of castration on the development of prostate adenocarcinoma from its precursor HGPIN and on the occurrence of androgen-independent, poorly differentiated carcinoma in TRAMP mice.
    Bono AV; Montironi R; Pannellini T; Sasso F; Mirone V; Musiani P; Iezzi M
    Prostate Cancer Prostatic Dis; 2008; 11(4):377-83. PubMed ID: 18379588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts.
    Ammirante M; Shalapour S; Kang Y; Jamieson CA; Karin M
    Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14776-81. PubMed ID: 25267627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer.
    Iglesias-Gato D; Chuan YC; Wikström P; Augsten S; Jiang N; Niu Y; Seipel A; Danneman D; Vermeij M; Fernandez-Perez L; Jenster G; Egevad L; Norstedt G; Flores-Morales A
    Carcinogenesis; 2014 Jan; 35(1):24-33. PubMed ID: 24031028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stat3 enhances the growth of LNCaP human prostate cancer cells in intact and castrated male nude mice.
    DeMiguel F; Lee SO; Lou W; Xiao X; Pflug BR; Nelson JB; Gao AC
    Prostate; 2002 Jul; 52(2):123-9. PubMed ID: 12111703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction.
    Lee GT; Kang DI; Ha YS; Jung YS; Chung J; Min K; Kim TH; Moon KH; Chung JM; Lee DH; Kim WJ; Kim IY
    Br J Cancer; 2014 Mar; 110(6):1634-44. PubMed ID: 24518599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the autochthonous transgenic adenocarcinoma of the mouse prostate (TRAMP) as a model to study effects of castration therapy.
    Wikström P; Lindahl C; Bergh A
    Prostate; 2005 Feb; 62(2):148-64. PubMed ID: 15389804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer.
    Mostaghel EA; Page ST; Lin DW; Fazli L; Coleman IM; True LD; Knudsen B; Hess DL; Nelson CC; Matsumoto AM; Bremner WJ; Gleave ME; Nelson PS
    Cancer Res; 2007 May; 67(10):5033-41. PubMed ID: 17510436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen-independent prostate cancer progression in the TRAMP model.
    Gingrich JR; Barrios RJ; Kattan MW; Nahm HS; Finegold MJ; Greenberg NM
    Cancer Res; 1997 Nov; 57(21):4687-91. PubMed ID: 9354422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.
    Zhao XY; Malloy PJ; Krishnan AV; Swami S; Navone NM; Peehl DM; Feldman D
    Nat Med; 2000 Jun; 6(6):703-6. PubMed ID: 10835690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.